Mallinckrodt Plc - Company Profile

Powered by

All the data and insights you need on Mallinckrodt Plc in one report.

  • Save hours of research time and resources with
    our up-to-date Mallinckrodt Plc Strategy Report

  • Understand Mallinckrodt Plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Mallinckrodt Plc: Segment Analysis

Business Description

Mallinckrodt Plc (Mallinckrodt) is a pharmaceutical company that develops, manufactures, markets, and distributes generic and branded specialty pharmaceutical products and therapies. These drugs find use in specialty areas such as rheumatology, nephrology, neurology, pulmonology, ophthalmology, analgesics, gastrointestinal, immunotherapy, oncology and other various therapy areas.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

The company focuses on to develop new products and enhance existing ones in the specialty pharmaceuticals area. Major Specialty Brand pipeline products include StrataGraft for severe burns and complex skin defects; Terlipressin for treatment of hepatorenal syndrome type1; SLN-MNK_2, SLN-MNK-3 for hepatic encephalopathy; and SLN500 for inflammation. Its R&D facilities related to the Specialty Generics segment is developed in Webster Groves, Missouri. In FY2022, the company spent US$85.6 million on R&D activities and declined 29.4% YoY.

Business Segments

Overview

Manufactures and markets branded pharmaceutical therapies and products. Focuses on therapy areas include immunotherapy, neonatal critical care respiratory therapy, central nervous system drugs, neurology, nephrology, rheumatology, pulmonology,oncology and ophthalmology analgesics and gastrointestinal products. Key branded products include Acthar Gel for the treatment of systemic lupus erythematosus, infantile spasms, multiple sclerosis, dermatomyositis, respiratory manifestations of symptomatic sarcoidosis, collagen, dermatologic, ophthalmic, rheumatic, allergic, and respiratory diseases; Inomax for improving oxygenation; Ofirmev for management of pain; Therakos for immunotherapy treatment platforms; and Amitiza for chronic idiopathic constipation; Strata Graft for the treatment of thermal skin burning issues. Markets branded products to physicians include neurologists, rheumatologists, nephrologists, neonatologists, pulmonologists, ophthalmologists and surgeons; pharmacy buyers; pharmacists; ambulatory surgical centers; hospital procurement departments; and specialty pharmacies. Aims to increase patient access and utilization of its existing products, develop innovative new therapies and next-generation devices; advance pipeline products; and intends to expand the size and profitability through acquisition or license products which are strategically aligned with its product portfolio.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Overview

Manufactures and markets active pharmaceutical ingredients (API) and specialty generic drugs. - Key product categories include generic products, addiction treatment products, compounding powders and unit does products. - Major API products include hydrocodone (API) and hydrocodone-containing tablets, acetaminophen (API) products, oxycodone (API) and oxycodone-containing tablets and other controlled substances. - Markets specialty generics products through specialty pharmaceutical distributors, drug distributors, retail pharmacy chains, pharmaceutical benefit managers having mail order pharmacies, food store chains with pharmacies, and hospital buying groups. Strives to manufacture large quality of products, customized products, responsive technical services, and timely delivery to customers.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Subscribe for access to business segment analysis Subscribe for access to business segment analysis Find out more



Geographical Segments

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Gain a 360-degree view of Mallinckrodt Plc and make more informed decisions for your business Gain a 360-degree view of Mallinckrodt Plc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward